BriaCell Therapeutics Corp.
Hedge Funds Holdings
Last updated:
BriaCell Therapeutics Corp.‘s stocks are currently a part of 16 hedge funds’ portfolios, which represents 15.95% of the total amount of its stocks outstanding. This makes up a total of 2.47M shares of BriaCell Therapeutics Corp.. Compared to the previous quarter, the number fell by -7.08% or -188.52K shares fewer. As for the holding position changes, 18.75% (3) of current hedge fund investors increased the number of shares held, 12.5% (2) of current holders sold a part of the shares held, and 12.5% (2) closed the holdings completely. 4 hedge funds are new holders of BriaCell Therapeutics Corp. stock in Q1 2023, it is 25% of total holders.
Hedge funds holding BriaCell Therapeutics Corp. (Q2 2020 – Q1 2023)
| Q2 2020 | 1 |
|---|---|
| Q3 2020 | 1 |
| Q4 2020 | 0 |
| Q1 2021 | 8 |
| Q2 2021 | 22 |
| Q3 2021 | 19 |
| Q4 2021 | 18 |
| Q1 2022 | 16 |
| Q2 2022 | 20 |
| Q3 2022 | 18 |
| Q4 2022 | 20 |
| Q1 2023 | 16 |
Hedge funds changes in BriaCell Therapeutics Corp. positions (Q2 2020 – Q1 2023)
| Q2 2020 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2020 | 0 | 0 | 0 | 0 | 1 |
| Q4 2020 | 0 | 0 | 0 | 1 | -1 |
| Q1 2021 | 8 | 0 | 0 | 0 | 0 |
| Q2 2021 | 17 | 4 | 0 | 3 | -2 |
| Q3 2021 | 11 | 2 | 5 | 14 | -13 |
| Q4 2021 | 7 | 7 | 3 | 8 | -7 |
| Q1 2022 | 4 | 5 | 5 | 6 | -4 |
| Q2 2022 | 8 | 6 | 4 | 4 | -2 |
| Q3 2022 | 4 | 7 | 5 | 6 | -4 |
| Q4 2022 | 7 | 5 | 4 | 5 | -1 |
| Q1 2023 | 4 | 3 | 2 | 2 | 5 |
Hedge funds changes in BriaCell Therapeutics Corp. stock options (Q2 2020 – Q1 2023)
| Q2 2020 | 0 | 0 |
|---|---|---|
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 14,013,000 | 10,264,000 |
| Q1 2022 | 15,528,000 | 11,188,000 |
| Q2 2022 | 8,425,000 | 3,457,000 |
| Q3 2022 | 6,281,000 | 3,527,000 |
| Q4 2022 | 3,541,151 | 1,789,960 |
| Q1 2023 | 702,068,000 | 1,000 |